ZDHHC18 and central nervous system cancer: Thus, expression levels of ZDHHC18 and ZDHHC23 were positively correlated with the increasing tumor grade, both in the publicly available databases and in our cohort of primary tumor specimens, and might, therefore, constitute novel prognostic biomarkers for gliomas.